Pediatric multiple sclerosis report of 14 cases

Area of Science:

• Neurology
• Pediatrics
• Immunology

Background:

• Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
• While typically diagnosed in young adults, MS can affect children and adolescents.
• Early diagnosis and management are crucial for long-term outcomes.

Purpose of the Study:

• To present clinical data on pediatric multiple sclerosis patients.
• To evaluate the utility of paraclinical investigations in diagnosing childhood MS.
• To highlight the varied clinical presentations and disease course in young MS patients.

Main Methods:

• Retrospective analysis of clinical data from 14 pediatric MS patients (onset age 2-15 years) admitted between 1980-1992.
• Review of initial symptoms, disease course (relapsing-remitting), and number of attacks.
• Analysis of paraclinical examinations including cerebrospinal fluid (CSF) analysis, brain CT, cranial MRI, and evoked potentials (visual, brainstem acoustic, somatosensory).

Main Results:

• 14 patients with clinically definite MS and a relapsing-remitting course were identified.
• Initial symptoms ranged from motor/sensory impairment to diffuse encephalopathy.
• Paraclinical findings included abnormal brain MRI (5/6), abnormal visual evoked potentials (7/8), and abnormal brainstem acoustic/somatosensory evoked potentials (4/8 each). CSF analysis was normal in 12/23 active disease samples.

Conclusions:

• Pediatric multiple sclerosis is a significant clinical entity.
• Diagnosis relies on clinical presentation, but paraclinical investigations are vital for confirming demyelinating disorders in children.
• Evoked potentials and MRI are valuable tools in the diagnostic workup of childhood MS.